These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23503972)

  • 1. Ovarian epithelial tumors and reproductive factors: a systematic review.
    Schüler S; Ponnath M; Engel J; Ortmann O
    Arch Gynecol Obstet; 2013 Jun; 287(6):1187-204. PubMed ID: 23503972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
    Riman T; Persson I; Nilsson S
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and hormonal factors and ovarian cancer.
    Chiaffarino F; Pelucchi C; Parazzini F; Negri E; Franceschi S; Talamini R; Conti E; Montella M; La Vecchia C
    Ann Oncol; 2001 Mar; 12(3):337-41. PubMed ID: 11332145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
    Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
    Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
    Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
    PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of the epidemiology of ovarian cancer.
    La Vecchia C; Franceschi S; Liberati A; Gallus G; Tognoni G
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):175-82. PubMed ID: 6368240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of reproductive factors and risk of epithelial ovarian cancer.
    Hankinson SE; Colditz GA; Hunter DJ; Willett WC; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
    Cancer; 1995 Jul; 76(2):284-90. PubMed ID: 8625104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
    Modugno F; Ness RB; Wheeler JE
    Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    Gupta M; Babic A; Beck AH; Terry K
    Hum Pathol; 2016 Aug; 54():82-91. PubMed ID: 27068525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers.
    Perri T; Lifshitz D; Sadetzki S; Oberman B; Meirow D; Ben-Baruch G; Friedman E; Korach J
    Fertil Steril; 2015 May; 103(5):1305-12. PubMed ID: 25792249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and neoplasia of the ovary.
    Stanford JL
    Contraception; 1991 Jun; 43(6):543-56. PubMed ID: 1868732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic types of epithelial ovarian cancer: have they different risk factors?
    Kurian AW; Balise RR; McGuire V; Whittemore AS
    Gynecol Oncol; 2005 Feb; 96(2):520-30. PubMed ID: 15661246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IPPF statement on oral contraceptives and cancer of the breast.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women.
    Tok EC; Ertunc D; Tataroglu C; Yazici G; Kanat H; Dilek S
    Int J Gynecol Cancer; 2006; 16(2):501-6. PubMed ID: 16681718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.